Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT02642965 · COMPLETED

Trial details

NCT number: NCT02642965
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Post Cytotoxic Therapy Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia

Start date: 2016-05-02
Primary completion: 2018-12-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.